On Monday, Johnson & Johnson (NYSE:JNJ) closed at 126.99, 1.56% below its 52-week high of 129.00, set on Mar 15, 2017."
You read it on the Financial Time's website, which is a pretty accurate source of information as far as financial data for listed companies are concerned.
It didn't mention, however, that JNJ stock is flirting with record highs, thanks to an upgrade from JPMorgan, which now rates JNJ overweight with a $140 price target.
Many JNJ investors will jump of joy if those predictions turn out to be true, of course.
But here's a) something you should consider if you plan to add JNJ to your portfolio today at prevailing prices following yesterday's 2.7% rise in its stock price, and b) what such a price tag could mean for your investment strategy.
